Astera Labs (NASDAQ:ALAB) Receives New Coverage from Analysts at Morgan Stanley

Morgan Stanley began coverage on shares of Astera Labs (NASDAQ:ALAB) in a research report report published on Monday morning, Marketbeat reports. The firm issued an overweight rating and a $81.00 price target on the stock.

A number of other brokerages have also recently weighed in on ALAB. Barclays started coverage on shares of Astera Labs in a research report on Monday. They set an overweight rating and a $85.00 price target on the stock. Stifel Nicolaus assumed coverage on Astera Labs in a research note on Monday. They issued a buy rating and a $81.00 target price for the company. JPMorgan Chase & Co. started coverage on Astera Labs in a research report on Monday. They set an overweight rating and a $85.00 price target on the stock. Roth Mkm began coverage on Astera Labs in a research note on Monday. They set a buy rating and a $85.00 target price for the company. Finally, Northland Securities initiated coverage on shares of Astera Labs in a research note on Monday, March 25th. They issued an outperform rating and a $85.00 price target on the stock. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of Buy and a consensus price target of $86.09.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $70.92 on Monday. Astera Labs has a fifty-two week low of $50.61 and a fifty-two week high of $95.21.

Insider Activity at Astera Labs

In related news, Director Jack R. Lazar bought 10,000 shares of the stock in a transaction that occurred on Friday, March 22nd. The shares were acquired at an average price of $36.00 per share, with a total value of $360,000.00. Following the completion of the transaction, the director now owns 165,000 shares in the company, valued at $5,940,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Institutional Trading of Astera Labs

An institutional investor recently bought a new position in Astera Labs stock. Allspring Global Investments Holdings LLC bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor bought 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned 0.16% of Astera Labs as of its most recent filing with the SEC.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.